Cargando…
Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity
The HRAS, NRAS, and KRAS genes are collectively mutated in a fifth of all human cancers. These mutations render RAS GTP-bound and active, constitutively binding effector proteins to promote signaling conducive to tumorigenic growth. To further elucidate how RAS oncoproteins signal, we mined RAS inte...
Autores principales: | Adhikari, Hema, Kattan, Walaa E., Kumar, Shivesh, Zhou, Pei, Hancock, John F., Counter, Christopher M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429657/ https://www.ncbi.nlm.nih.gov/pubmed/34504076 http://dx.doi.org/10.1038/s41467-021-25523-5 |
Ejemplares similares
-
Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability
por: Adhikari, Hema, et al.
Publicado: (2018) -
Targeting plasma membrane phosphatidylserine content to inhibit oncogenic KRAS function
por: Kattan, Walaa E, et al.
Publicado: (2019) -
Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish
por: Yan, Chuan, et al.
Publicado: (2015) -
EFR3A: a new raft domain organizing protein?
por: Trybus, Magdalena, et al.
Publicado: (2023) -
Targeting PI4KA sensitizes refractory leukemia to chemotherapy by modulating the ERK/AMPK/OXPHOS axis
por: Jiang, Xiuxing, et al.
Publicado: (2022)